Lupus Flares and Histological Renal Activity at the End of the Treatment (LuFla)
This trial is active, not recruiting.
|Sponsor||Hospital de Clinicas José de San Martín|
|Start date||January 2014|
|End date||November 2016|
|Trial size||36 participants|
|Trial identifier||NCT02313974, HSM LuNe|
At this moment, the duration of the treatment in Proliferative Lupus Nephritis has not been determined.
Almost 30 percent of patients in total remission during or after a treatment, will relapse in the first 5 years.
The factors associated to Renal relapses are not completly known. The investigators think that an histological control study performed to patient with complete remission for a year at the end of a 3 years treatment could help us to know which patients are going to relapse.
time frame: 2 years
Male or female participants from 18 years up to 70 years old.
Inclusion Criteria : - Patients between 18 and 70 years old with Proliferative Lupus Nephritis - 3 years treatment with a 6 month induction therapy and 2 years and a half of treatment maintenence Exclusion Criteria : - Membranous Nephropaty - Mesangial Nephropathy - Less than 3 years treatment - Less than 1 year of complete remission
|Official title||Lupus Flares and Histological Renal Activity at the End of the Treatment|
|Principal investigator||Marcelo A De Rosa, Physician|
Call for more information